Mersana Therapeutics logo
Mersana Therapeutics MRSN
$ 1.61 -7.76%

Quarterly report 2024-Q3
added 11-13-2024

report update icon

Mersana Therapeutics P/E Ratio 2011-2024 | MRSN

Annual P/E Ratio Mersana Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-3.35 -2.77 -1.82 -12.7 -10.8 -1.64 -4.67 - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-1.64 -12.7 -5.39